Cargando…
Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma
Purpose: To use a modeled analysis to examine the cost-effectiveness of utilizing fractional exhaled nitric oxide (FeNO) as a biomarker to aid in the identification of omalizumab responders in patients with moderate-to-severe allergic asthma. Omalizumab is a biological drug used to treat asthma in a...
Autores principales: | Brooks, Elizabeth A, Massanari, Marc, Hanania, Nicola A, Weiner, Daniel J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497051/ https://www.ncbi.nlm.nih.gov/pubmed/31114270 http://dx.doi.org/10.2147/CEOR.S177207 |
Ejemplares similares
-
Fractional exhaled nitric oxide (FeNo) in different asthma phenotypes
por: Gemicioglu, Bilun, et al.
Publicado: (2014) -
Fractional exhaled nitric oxide (FeNO) measurement in asthma and rhinitis
por: Gevorgyan, Artur, et al.
Publicado: (2013) -
Fractional exhaled nitric oxide (FeNO): the future of asthma care?
por: Wang, Kay, et al.
Publicado: (2023) -
296 The Relationship of Fractional Exhaled Nitric Oxide (FeNO) and Acute Exacerbation of Childhood Asthma
por: Rha, Yeong Ho, et al.
Publicado: (2012) -
Qualitative study on perceptions of use of Fractional Exhaled Nitric Oxide (FeNO) in asthma reviews
por: Santillo, Marta, et al.
Publicado: (2022)